Oral ONC201 in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT02863991 · TERMINATED
Trial details
- NCT number
- NCT02863991
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2019-09-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.